Hydroxyurea: possible relationship of cytotoxicity to inhibition of skin carcinogenesis.
D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D003436:Croton Oil / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis*; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005260:Female; D006918:Hydroxyurea / Q000494:pharmacology* / Q000633:toxicity; D007274:Injections, Intraperitoneal; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D012878:Skin Neoplasms / Q000139:chemically induced*; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014316:Tritium
D002273:Carcinogens; D004273:DNA, Neoplasm; D014316:Tritium; D003436:Croton Oil; D004247:DNA; D013936:Thymidine; D006918:Hydroxyurea